Private Advisor Group, LLC Dynavax Technologies Corp Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$7.45 - $12.83 $2,346 - $4,041
-315 Reduced 3.01%
10,157 $128,000
Q1 2022

May 12, 2022
SELL
$9.75 - $14.44 $9,750 - $14,440
-1,000 Reduced 8.72%
10,472 $114,000
Q4 2021

Feb 10, 2022
BUY
$13.17 - $20.94 $151,086 - $240,223
11,472 New
11,472 $161,000
Q3 2020

Nov 02, 2020
SELL
$4.32 - $11.7 $13,284 - $35,977
-3,075 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$2.94 - $9.1 $9,040 - $27,982
3,075 New
3,075 $27,000

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email